Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

NCT01443104 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2119

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Angina Pectoris
Myocardial Infarction

Interventions

DEVICE: Sirolimus-eluting stent with a bioresorbable polymer (Orsiro)
DEVICE: Everolimus-eluting stent with a durable polymer

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]
[object Object]